congenital heart disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients diagnosed with simple congenital heart disease by preoperative color Doppler ultrasound and treated with interventional occlusion or extracorporeal circulation surgery. The diagnosis and surgical indications of congenital heart disease are based on the Clinical Guidelines for Cardiovascular Surgery (2011 edition) compiled by the Chinese Medical Association; 2. Aged between 3-70 years, no gender limit; 3. No serious heart, lung, kidney, liver dysfunction or metabolic diseases; 4. The patient and the patient's family understand the situation of this experiment and agree to participate in all terms of this study, sign the informed consent approved by the Ethics Committee, agree to accept the current treatment plan, and can cooperate with the experiment.
Exclusion criteria
Exclusion criteria: 1. Patients who cannot take oral or absorb digestive tract drugs; 2. Participate in other clinical trials on probiotics within 30 days before enrollment; 3. Patients who have received cardiovascular surgery before surgery or who need to receive other types of great vascular surgery during the same period; 4. Pregnant and lactating patients; 5. Patients with severe neurological or psychiatric diseases; 6. Patients with autoimmune diseases, immune deficiency diseases, or a history of organ transplantation; 7. Those who were considered unsuitable for inclusion by the researchers.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| gastrointestinal symptom score; | — |
Secondary
| Measure | Time frame |
|---|---|
| white blood cell count;renal function;cardiac function; | — |
Countries
China